3D MRI-based brachytherapy for cervical cancer

References

• Gerbaulet A, Pötter R, Haie-Meder C. Cervix cancer. In: The GEC ESTRO Handbook of Brachytherapy. Gerbaulet A, Pötter R, Mazeron JJ et al. (Eds). ESTRO, Brussels, Belgium, 301–363 (2002).
   Google Scholar
• Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Engl. J. Med.340(15), 1137–1143 (1999).
   PubMed Web of Science ®Google Scholar
• Green J, Kirwan J, Tierney J et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.Cochrane Database Syst. Rev.20(3), CD002225 (2005).
   Google Scholar
• Haie-Meder C, Pötter R, Van Limbergen E et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother. Oncol.74(3), 235–245 (2005).
   PubMed Web of Science ®Google Scholar
• Pötter R, Haie-Meder C, Van Limbergen E et al. Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (II): concepts and terms in 3D image based treatment planning in cervix cancer brachytherapy: aspects of 3D imaging, radiation physics, radiobiology, and 3D dose volume parameters. Radiother. Oncol.78(1), 67–77 (2006).
   PubMed Web of Science ®Google Scholar
• International Commission on Radiation Units and Measurements, ICRU Report 38. Dose and Volume Specification For Reporting Intracavitary Therapy In Gynaecology. International Commission on Radiation Units and Measurements, MD, USA (1985).
   Google Scholar
• Kirisits C, Pötter R, Lang S et al. Dose and volume parameters for MRI based treatment planning in intracavitary brachytherapy of cervix cancer. Int. J. Radiat. Oncol. Biol. Phys.62(3), 901–911 (2005).
   PubMed Web of Science ®Google Scholar
• Nag S. Controversies and new developments in gynecologic brachytherapy: image-based intracavitary brachytherapy for cervical carcinoma. Semin. Radiat. Oncol.16(3), 164–167 (2006).
   PubMed Web of Science ®Google Scholar
• Wachter-Gerstner N, Wachter S, Reinstadler E et al. The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial. Radiother. Oncol.68(1), 51–59 (2003).
   PubMed Web of Science ®Google Scholar
• Mitchell DG, Snyder B, Coakley F et al. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J. Clin. Oncol.24(36), 5687–5694 (2006).
   PubMed Web of Science ®Google Scholar
• Boss E, Barentsz J, Massugen L et al. The role of MR imaging in invasive cervical carcinoma. Eur. Radiol.10, 256–270 (2000).
   PubMed Web of Science ®Google Scholar
• Viswanathan AN, Dimopoulos J, Kirisits C, Berger D, Pötter R. CT- versus MRI-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int. J. Radiat. Oncol. Biol. Phys.68, 491–498 (2007).
   PubMed Web of Science ®Google Scholar
• Kaur H, Silverman PM, Iyer RB, Verschraegen CF, Eifel PJ, Charnsangavej C. Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am. J. Roentgenol.180(6), 1621–1631 (2003).
   PubMed Web of Science ®Google Scholar
• Shin KH, Kim TH, Cho JK et al. CT-guided intracavitary radiotherapy for cervical cancer: comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose–volume parameters. Int. J. Radiat. Oncol. Biol. Phys.64(1), 197–204 (2006).
   PubMed Web of Science ®Google Scholar
• Schoeppel SL, LaVigne ML, Martel MK et al. Three-dimensional treatment planning of intracavitary gynecologic implants: analysis of ten cases and implications for dose specification. Int. J. Radiat. Oncol. Biol. Phys.28, 277–283 (1993).
   Google Scholar
• Kim RY, Pareek P. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose–volume histograms. Brachytherapy2, 200–206 (2003).
   PubMedGoogle Scholar
• Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J. Clin. Oncology.17(1), 41–45 (1999).
   PubMed Web of Science ®Google Scholar
• Reinhardt MJ, Ehritt-Braun C, Vogelgesang D et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology218(3), 776–782 (2001).
   PubMed Web of Science ®Google Scholar
• Lin LL, Mutic S, Malyapa RS et al. Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix. Int. J. Radiat. Oncol. Biol. Phys.63(5), 1494–1501 (2005).
   PubMedGoogle Scholar
• Mutic S, Grigsby PW, Low DA et al. PET-guided three-dimensional treatment planning of intracavitary gynecologic implants. Int. J. Radiat. Oncol. Biol. Phys.52(4), 1104–1110 (2002).
   PubMedGoogle Scholar
• Malyapa RS, Mutic S, Low DA et al. Physiologic FDG-PET three-dimensional brachytherapy treatment planning for cervical cancer. Int. J. Radiat. Oncol. Biol. Phys.54(4), 1140–1146 (2002).
   PubMed Web of Science ®Google Scholar
• Datta NR, Srivastava A, Maria Das KJ, Gupta A, Rastogi N. Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer. Brachytherapy5(4), 223–229 (2006).
   PubMed Web of Science ®Google Scholar
• Dimopoulos J, Kirisits C, Petric P et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. Int. J. Radiat. Oncol. Biol. Phys.66(1), 83–90 (2006).
   PubMed Web of Science ®Google Scholar
• Georg P, Kirisits C, Hammer J et al. Correlation of dose volume parameters, rectoscopy findings and rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Brachytherapy5(2), 81 (2008).
   Google Scholar
• Pötter R, Dimopoulos J, Georg P et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother. Oncol.83(2), 148–155 (2007).
   PubMed Web of Science ®Google Scholar
• Pötter R. Modern imaging in brachytherapy. In:The GEC ESTRO Handbook of Brachytherapy. Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E (Eds). Euopean Society for Therapeutic Radiology and Oncology, Brussels, Belgium, 123–151 (2002).
   Google Scholar
• Wachter-Gerstner N, Wachter S, Reinstadler E et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose–volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother. Oncol.68(3), 269–276 (2003).
   PubMedGoogle Scholar
• Chajon E, Dumas I, Touleimat M et al. Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer. Int. J. Radiat. Oncol. Biol. Phys.69(3), 955–961 (2007).
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J. MRI-Guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int. J. Radiat. Oncol. Biol. Phys. (2008).
   Google Scholar
• De Brabandere M, Mousa AG, Nulens A, Swinnen A, Van Limbergen E. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother. Oncol. (2007) (Epub ahead of print).
   Google Scholar
• Dimopoulos J, Schard G, Berger D et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, patho-anatomical structures and organs at risk. Int. J. Radiat. Oncol. Biol. Phys.64(5), 1380–1388 (2006).
   PubMed Web of Science ®Google Scholar
• Nag S, Cardenes H, Chang S et al.; Image-Guided Brachytherapy Working Group. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys.60(4), 1160–1172 (2004).
   PubMed Web of Science ®Google Scholar
• Kirisits C, Lang S, Dimopoulos J et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning and dosimetric results. Int. J. Radiat. Oncol. Biol. Phys.65, 624–630 (2006).
   PubMed Web of Science ®Google Scholar
• Fellner C, Pötter R, Knocke TH et al. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother. Oncol.58, 53–62 (2001).
   PubMed Web of Science ®Google Scholar
• Pelloski CE, Palmer M, Chronowski GM et al. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary brachytherapy for cervical cancer. Int. J. Radiat. Oncol. Biol. Phys.62, 131–137 (2005).
   PubMedGoogle Scholar
• Lang S, Kirisits C, Dimopoulos J et al. Treatment planning for MRI assisted brachytherapy of gynaecological malignancies based on total dose constraints. Int. J. Radiat. Oncol. Biol. Phys.69(2), 619–627 (2007).
   PubMedGoogle Scholar
• Petereit DG, Pearcy R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? Int. J. Radiat. Oncol. Biol. Phys.43, 359–366 (1999).
   PubMedGoogle Scholar
• Pötter R, Knocke TH, Fellner C et al. Definitive radiotherapy based on HDR brachytherapy with Iridium-192 in cervix cancer- report on the recent Vienna University Hospital experience (1993–1997) compared to the preceding period, referring to ICRU 38 recommendations. Bull. Cancer Radiother.4, 159–172 (2000).
   Google Scholar
• Stitt JA, Fowler JF, Thomadsen BR et al. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations. Int. J. Radiat. Oncol. Biol. Phys.24, 335–348 (1992).
   PubMedGoogle Scholar
• Berger D, Dimopoulos J, Georg P et al. Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator. Int. J. Radiat. Oncol. Biol. Phys.67, 1451–1459 (2007).
   PubMedGoogle Scholar